
    
      64 cases were randomly divided into four groups, In each group, dexmedetomidine target plasma
      concentration are 0, 0.4, 0.6, 0.8 ng/ml. Dexmedetomidine administered 15 min before target
      controlled infusion of propofol. The propofol infusion was started to provide a target
      effect-site concentration of 1.0ug/ml, and increased by 0.2ug/ml until loss of consciousness
      when the effect-site concentration and target concentration equilibrium.
    
  